BRAINSTORM CELL THERAPEUTICS INC. Income (Loss) from Continuing Operations, Per Basic and Diluted Share
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) reported Income (Loss) from Continuing Operations, Per Basic and Diluted Share of -$0.17 per share for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare · last filed 2021-08-05
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2021-06-30 was -$0.17.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2021-03-31 was -$0.19.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2020-09-30 was -$0.14.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations, per basic and diluted share for the quarter ending 2020-06-30 was -$0.25.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations, per basic and diluted share for fiscal 2018 was -$0.70.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations, per basic and diluted share for fiscal 2017 was -$0.26.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations, per basic and diluted share for fiscal 2016 was -$0.27.
- BRAINSTORM CELL THERAPEUTICS INC. income (loss) from continuing operations, per basic and diluted share for fiscal 2015 was -$0.46.
| Period end | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 12 month as first filed | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 147 month | Income (Loss) from Continuing Operations, Per Basic and Diluted Share 159 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$0.17 10-Q · filed 2021-08-05 | -$0.36 10-Q · filed 2021-08-05 | ||||||||
| 2021-03-31 | -$0.19 10-Q · filed 2021-04-26 | |||||||||
| 2020-09-30 | -$0.14 10-Q · filed 2020-10-15 | -$0.70 10-Q · filed 2020-10-15 | ||||||||
| 2020-06-30 | -$0.25 10-Q · filed 2021-08-05 | -$0.56 10-Q · filed 2021-08-05 | ||||||||
| 2020-03-31 | -$0.32 10-Q · filed 2021-04-26 | |||||||||
| 2019-09-30 | -$0.25 10-Q · filed 2020-10-15 | -$0.72 10-Q · filed 2020-10-15 | ||||||||
| 2019-06-30 | -$0.23 10-Q · filed 2020-08-05 | -$0.47 10-Q · filed 2020-08-05 | ||||||||
| 2019-03-31 | -$0.24 10-Q · filed 2020-05-07 | |||||||||
| 2018-12-31 | -$0.70 10-K · filed 2019-04-01 | |||||||||
| 2018-09-30 | -$0.15 10-Q · filed 2019-11-14 | -$0.43 10-Q · filed 2019-11-14 | ||||||||
| 2018-06-30 | -$0.16 10-Q · filed 2019-08-13 | -$0.28 10-Q · filed 2019-08-13 | ||||||||
| 2018-03-31 | -$0.12 10-Q · filed 2019-05-10 | |||||||||
| 2017-12-31 | -$0.26 10-K · filed 2019-04-01 | |||||||||
| 2017-09-30 | -$0.13 10-Q · filed 2018-10-29 | -$0.28 10-Q · filed 2018-10-29 | ||||||||
| 2017-06-30 | -$0.06 10-Q · filed 2018-07-23 | -$0.15 10-Q · filed 2018-07-23 | ||||||||
| 2017-03-31 | -$0.10 10-Q · filed 2018-05-14 | |||||||||
| 2016-12-31 | -$0.27 10-K · filed 2018-03-08 | |||||||||
| 2016-09-30 | -$0.09 10-Q · filed 2017-10-17 | -$0.23 10-Q · filed 2017-10-17 | ||||||||
| 2016-06-30 | -$0.05 10-Q · filed 2017-08-14 | -$0.15 10-Q · filed 2017-08-14 | ||||||||
| 2016-03-31 | -$0.10 10-Q · filed 2017-05-15 | |||||||||
| 2015-12-31 | -$0.46 10-K · filed 2017-03-29 | |||||||||
| 2015-09-30 | -$0.14 10-Q · filed 2016-11-14 | -$0.39 10-Q · filed 2016-11-14 | ||||||||
| 2015-06-30 | -$0.12 10-Q · filed 2016-08-11 | -$0.24 10-Q · filed 2016-08-11 | ||||||||
| 2015-03-31 | -$0.12 10-Q · filed 2016-05-10 | $0.12 10-Q · filed 2015-05-14 | ||||||||
| 2014-12-31 | -$0.68 10-K · filed 2016-03-09 | $0.68 10-K · filed 2015-03-26 | ||||||||
| 2014-09-30 | -$0.16 10-Q · filed 2015-11-16 | $0.16 10-Q · filed 2014-11-13 | -$0.50 10-Q · filed 2015-11-16 | $0.50 10-Q · filed 2014-11-13 | ||||||
| 2014-06-30 | -$0.16 10-Q · filed 2015-08-13 | $0.01 10-Q · filed 2014-08-12 | -$0.34 10-Q · filed 2015-08-13 | $0.02 10-Q · filed 2014-08-12 | ||||||
| 2014-03-31 | $0.18 10-Q · filed 2015-05-14 | $0.01 10-Q · filed 2014-05-13 | ||||||||
| 2013-12-31 | $0.46 10-K · filed 2015-03-26 | $0.03 10-K · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | $0.10 10-Q · filed 2014-11-13 | -$0.01 10-Q · filed 2013-11-14 | $0.36 10-Q · filed 2014-11-13 | -$0.02 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | $0.01 10-Q · filed 2014-08-12 | -$0.01 10-Q · filed 2013-08-14 | $0.02 10-Q · filed 2014-08-12 | -$0.02 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | $0.01 10-Q · filed 2014-05-13 | -$0.01 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | $0.02 10-K · filed 2014-03-27 | -$0.02 10-K · filed 2013-03-14 | $0.00 10-K · filed 2013-03-14 | |||||||
| 2012-09-30 | -$0.01 10-Q · filed 2013-11-14 | -$0.02 10-Q · filed 2013-11-14 | ||||||||
| 2012-06-30 | -$0.01 10-Q · filed 2013-08-14 | $0.01 10-Q/A · filed 2012-08-29 | -$0.01 10-Q · filed 2013-08-14 | $0.01 10-Q/A · filed 2012-08-29 | ||||||
| 2012-03-31 | -$0.01 10-Q · filed 2013-05-09 | $0.01 10-Q · filed 2012-05-11 | ||||||||
| 2011-12-31 | -$0.03 10-K · filed 2013-03-14 | $0.03 10-K · filed 2012-03-15 | ||||||||
| 2011-09-30 | -$0.01 10-Q · filed 2012-11-13 | $0.01 10-Q · filed 2011-11-14 | -$0.02 10-Q · filed 2012-11-13 | $0.02 10-Q · filed 2011-11-14 | ||||||
| 2011-06-30 | $0.01 10-Q/A · filed 2012-08-29 | $0.02 10-Q/A · filed 2012-08-29 | ||||||||
| 2011-03-31 | $0.01 10-Q · filed 2012-05-11 | |||||||||
| 2010-12-31 | $0.03 10-K · filed 2012-03-15 | |||||||||
| 2010-09-30 | $0.01 10-Q · filed 2011-11-14 | $0.02 10-Q · filed 2011-11-14 | ||||||||
| 2010-06-30 | $0.01 10-Q/A · filed 2011-09-07 | $0.01 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |